Successful treatment of hairy cell leukemia variant with obinutuzumab

Ann Hematol. 2022 Mar;101(3):703-704. doi: 10.1007/s00277-021-04559-z. Epub 2021 Jun 4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antigens, CD / analysis
  • Antineoplastic Agents, Immunological / therapeutic use*
  • Humans
  • Leukemia, Hairy Cell / drug therapy*
  • Leukemia, Hairy Cell / pathology
  • Male
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Antigens, CD
  • Antineoplastic Agents, Immunological
  • obinutuzumab